T M L Tong

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Venues

Cardiovascular and interventional radiology

Trials

This page only lists publications with an associated author ORCID identifier.

Publications

T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology 47 (6) (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology 47 (6) (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology 47 (6) (2024)
T M L Tong, M Fiocco, J J van Duijn-de Vreugd, J Lutjeboer, F M Speetjens, F G J Tijl, M E Sitsen, R W M Zoethout, C H Martini, A L Vahrmeijer, R W van der Meer, C S P van Rijswijk, A R van Erkel, E Kapiteijn, M C Burgmans
Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases. Cardiovascular and interventional radiology (2024)
T M L Tong, M C Burgmans, F M Speetjens, A R van Erkel, R W van der Meer, C S P van Rijswijk, M A Jonker-Bos, C F M Roozen, M Sporrel-Blokland, J Lutjeboer, E L van Persijn van Meerten, C H Martini, R W M Zoethout, F G J Tijl, C U Blank, E Kapiteijn
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial. Cardiovascular and interventional radiology (2023)
T M L Tong, M C Burgmans, F M Speetjens, A R van Erkel, R W van der Meer, C S P van Rijswijk, M A Jonker-Bos, C F M Roozen, M Sporrel-Blokland, J Lutjeboer, E L van Persijn van Meerten, C H Martini, R W M Zoethout, F G J Tijl, C U Blank, E Kapiteijn
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial. Cardiovascular and interventional radiology 46 (3) (2023)
T M L Tong, M C Burgmans, F M Speetjens, A R van Erkel, R W van der Meer, C S P van Rijswijk, M A Jonker-Bos, C F M Roozen, M Sporrel-Blokland, J Lutjeboer, E L van Persijn van Meerten, C H Martini, R W M Zoethout, F G J Tijl, C U Blank, E Kapiteijn
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial. Cardiovascular and interventional radiology 46 (3) (2023)
T M L Tong, M K van der Kooij, F M Speetjens, A R van Erkel, R W van der Meer, J Lutjeboer, E L van Persijn van Meerten, C H Martini, R W M Zoethout, F G J Tijl, C U Blank, M C Burgmans, E Kapiteijn
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial. Trials 23 (1) (2022)
T M L Tong, M Samim, E Kapiteijn, T S Meijer, F M Speetjens, R Brüning, T H Schroeder, S El-Sanosy, H Maschke, F K Wacker, A Vogel, C L A Dewald, J J Goeman, M C Burgmans
Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis. Cardiovascular and interventional radiology 45 (9) (2022)

T M L Tong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

T M L Tong